We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XIFR
3126
XPLR Infrastructure LP
XIFR
$1.11B
$212K ﹤0.01%
+2,499
New +$209K
XRT icon
3127
State Street SPDR S&P Retail ETF
XRT
$458M
$211K ﹤0.01%
2,343
-19,679
-89% -$1.85M
OTLK icon
3128
Outlook Therapeutics
OTLK
$169M
$209K ﹤0.01%
+7,678
New +$274K
ABEV icon
3129
Ambev
ABEV
$48.4B
$208K ﹤0.01%
74,210
-1,372,168
-95% -$3.93M
BCE icon
3130
BCE
BCE
$20.3B
$208K ﹤0.01%
4,000
-556,900
-99% -$28.5M
PHX
3131
DELISTED
PHX Minerals
PHX
$208K ﹤0.01%
95,583
-11,168
-10% -$31.6K
AAMI
3132
Acadian Asset Management
AAMI
$2.94B
$208K ﹤0.01%
+8,168
New +$230K
CWCO icon
3133
Consolidated Water Co
CWCO
$484M
$207K ﹤0.01%
+19,456
New +$217K
KULR icon
3134
KULR Technology Group
KULR
$117M
$207K ﹤0.01%
+9,335
New +$216K
CAMT icon
3135
Camtek
CAMT
$6.53B
$206K ﹤0.01%
4,482
-27,194
-86% -$1.16M
WING icon
3136
Wingstop
WING
$3.67B
$204K ﹤0.01%
1,181
-1,692
-59% -$284K
SMED
3137
DELISTED
Sharps Compliance Corp
SMED
$202K ﹤0.01%
28,422
-69,029
-71% -$530K
ZVIA icon
3138
Zevia
ZVIA
$116M
$201K ﹤0.01%
+28,659
New +$280K
SVFAW
3139
CALL
DELISTED
SVF Investment Corp. Warrant
SVFAW
$201K ﹤0.01%
20,038
-30,953
-61% -$41K
ROVR
3140
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$200K ﹤0.01%
+20,454
New +$236K
IAI icon
3141
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.38B
$198K ﹤0.01%
+1,797
New +$199K
AMPS
3142
DELISTED
Altus Power
AMPS
$198K ﹤0.01%
18,954
-1,964
-9% -$19.9K
THCPW
3143
CALL
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$198K ﹤0.01%
20,296
SYRE icon
3144
Spyre Therapeutics
SYRE
$8.68B
$197K ﹤0.01%
1,665
-10,968
-87% -$1.73M
DDI
3145
DoubleDown Interactive
DDI
$575M
$196K ﹤0.01%
+12,720
New +$206K
NAUT icon
3146
Nautilus Biotechnolgy
NAUT
$152M
$195K ﹤0.01%
37,713
-128,613
-77% -$688K
BBH icon
3147
VanEck Biotech ETF
BBH
$409M
$194K ﹤0.01%
+1,029
New +$198K
EMAN
3148
DELISTED
eMagin Corporation
EMAN
$194K ﹤0.01%
+150,797
New +$302K
SPNE
3149
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$194K ﹤0.01%
+14,235
New +$204K
VMAC
3150
DELISTED
Vistas Media Acquisition Company Inc. Class A Common Stock
VMAC
$194K ﹤0.01%
+18,972
New +$192K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.